img

Global Frovatriptan Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Frovatriptan Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular those associated with menstruation. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head
Frovatriptan report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Frovatriptan market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Menstrual Migraines and Migraine with Aura are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Frovatriptan industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Frovatriptan key manufacturers include Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici, Menarini, Novartis, Almac, Glenmark Generics, Teva and Zambon, etc. Ligand Pharmaceuticals, Endo Pharmaceuticals, Doc Generici are top 3 players and held % sales share in total in 2022.
Frovatriptan can be divided into Hospital and Drug Store, etc. Hospital is the mainstream product in the market, accounting for % sales share globally in 2022.
Frovatriptan is widely used in various fields, such as Menstrual Migraines, Migraine with Aura and Migraine without Aura,, etc. Menstrual Migraines provides greatest supports to the Frovatriptan industry development. In 2022, global % sales of Frovatriptan went into Menstrual Migraines filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Frovatriptan market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Ligand Pharmaceuticals
Endo Pharmaceuticals
Doc Generici
Menarini
Novartis
Almac
Glenmark Generics
Teva
Zambon
Apotex
G.L. Pharma
Chanelle Pharma
Segment by Type
Hospital
Drug Store

Segment by Application


Menstrual Migraines
Migraine with Aura
Migraine without Aura

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Frovatriptan market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Frovatriptan, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Frovatriptan industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Frovatriptan in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Frovatriptan introduction, etc. Frovatriptan Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Frovatriptan market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Frovatriptan Market Overview
1.1 Frovatriptan Product Overview
1.2 Frovatriptan Market Segment by Type
1.2.1 Hospital
1.2.2 Drug Store
1.3 Global Frovatriptan Market Size by Type
1.3.1 Global Frovatriptan Market Size Overview by Type (2024-2034)
1.3.2 Global Frovatriptan Historic Market Size Review by Type (2024-2024)
1.3.3 Global Frovatriptan Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Frovatriptan Sales Breakdown by Type (2024-2024)
1.4.2 Europe Frovatriptan Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Frovatriptan Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Frovatriptan Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Frovatriptan Sales Breakdown by Type (2024-2024)
2 Global Frovatriptan Market Competition by Company
2.1 Global Top Players by Frovatriptan Sales (2024-2024)
2.2 Global Top Players by Frovatriptan Revenue (2024-2024)
2.3 Global Top Players by Frovatriptan Price (2024-2024)
2.4 Global Top Manufacturers Frovatriptan Manufacturing Base Distribution, Sales Area, Product Type
2.5 Frovatriptan Market Competitive Situation and Trends
2.5.1 Frovatriptan Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Frovatriptan Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Frovatriptan as of 2022)
2.7 Date of Key Manufacturers Enter into Frovatriptan Market
2.8 Key Manufacturers Frovatriptan Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Frovatriptan Status and Outlook by Region
3.1 Global Frovatriptan Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Frovatriptan Historic Market Size by Region
3.2.1 Global Frovatriptan Sales in Volume by Region (2024-2024)
3.2.2 Global Frovatriptan Sales in Value by Region (2024-2024)
3.2.3 Global Frovatriptan Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Frovatriptan Forecasted Market Size by Region
3.3.1 Global Frovatriptan Sales in Volume by Region (2024-2034)
3.3.2 Global Frovatriptan Sales in Value by Region (2024-2034)
3.3.3 Global Frovatriptan Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Frovatriptan by Application
4.1 Frovatriptan Market Segment by Application
4.1.1 Menstrual Migraines
4.1.2 Migraine with Aura
4.1.3 Migraine without Aura
4.2 Global Frovatriptan Market Size by Application
4.2.1 Global Frovatriptan Market Size Overview by Application (2024-2034)
4.2.2 Global Frovatriptan Historic Market Size Review by Application (2024-2024)
4.2.3 Global Frovatriptan Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Frovatriptan Sales Breakdown by Application (2024-2024)
4.3.2 Europe Frovatriptan Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Frovatriptan Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Frovatriptan Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Frovatriptan Sales Breakdown by Application (2024-2024)
5 North America Frovatriptan by Country
5.1 North America Frovatriptan Historic Market Size by Country
5.1.1 North America Frovatriptan Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Frovatriptan Sales in Volume by Country (2024-2024)
5.1.3 North America Frovatriptan Sales in Value by Country (2024-2024)
5.2 North America Frovatriptan Forecasted Market Size by Country
5.2.1 North America Frovatriptan Sales in Volume by Country (2024-2034)
5.2.2 North America Frovatriptan Sales in Value by Country (2024-2034)
6 Europe Frovatriptan by Country
6.1 Europe Frovatriptan Historic Market Size by Country
6.1.1 Europe Frovatriptan Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Frovatriptan Sales in Volume by Country (2024-2024)
6.1.3 Europe Frovatriptan Sales in Value by Country (2024-2024)
6.2 Europe Frovatriptan Forecasted Market Size by Country
6.2.1 Europe Frovatriptan Sales in Volume by Country (2024-2034)
6.2.2 Europe Frovatriptan Sales in Value by Country (2024-2034)
7 Asia-Pacific Frovatriptan by Region
7.1 Asia-Pacific Frovatriptan Historic Market Size by Region
7.1.1 Asia-Pacific Frovatriptan Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Frovatriptan Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Frovatriptan Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Frovatriptan Forecasted Market Size by Region
7.2.1 Asia-Pacific Frovatriptan Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Frovatriptan Sales in Value by Region (2024-2034)
8 Latin America Frovatriptan by Country
8.1 Latin America Frovatriptan Historic Market Size by Country
8.1.1 Latin America Frovatriptan Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Frovatriptan Sales in Volume by Country (2024-2024)
8.1.3 Latin America Frovatriptan Sales in Value by Country (2024-2024)
8.2 Latin America Frovatriptan Forecasted Market Size by Country
8.2.1 Latin America Frovatriptan Sales in Volume by Country (2024-2034)
8.2.2 Latin America Frovatriptan Sales in Value by Country (2024-2034)
9 Middle East and Africa Frovatriptan by Country
9.1 Middle East and Africa Frovatriptan Historic Market Size by Country
9.1.1 Middle East and Africa Frovatriptan Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Frovatriptan Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Frovatriptan Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Frovatriptan Forecasted Market Size by Country
9.2.1 Middle East and Africa Frovatriptan Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Frovatriptan Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Ligand Pharmaceuticals
10.1.1 Ligand Pharmaceuticals Company Information
10.1.2 Ligand Pharmaceuticals Introduction and Business Overview
10.1.3 Ligand Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Ligand Pharmaceuticals Frovatriptan Products Offered
10.1.5 Ligand Pharmaceuticals Recent Development
10.2 Endo Pharmaceuticals
10.2.1 Endo Pharmaceuticals Company Information
10.2.2 Endo Pharmaceuticals Introduction and Business Overview
10.2.3 Endo Pharmaceuticals Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Endo Pharmaceuticals Frovatriptan Products Offered
10.2.5 Endo Pharmaceuticals Recent Development
10.3 Doc Generici
10.3.1 Doc Generici Company Information
10.3.2 Doc Generici Introduction and Business Overview
10.3.3 Doc Generici Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Doc Generici Frovatriptan Products Offered
10.3.5 Doc Generici Recent Development
10.4 Menarini
10.4.1 Menarini Company Information
10.4.2 Menarini Introduction and Business Overview
10.4.3 Menarini Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Menarini Frovatriptan Products Offered
10.4.5 Menarini Recent Development
10.5 Novartis
10.5.1 Novartis Company Information
10.5.2 Novartis Introduction and Business Overview
10.5.3 Novartis Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Novartis Frovatriptan Products Offered
10.5.5 Novartis Recent Development
10.6 Almac
10.6.1 Almac Company Information
10.6.2 Almac Introduction and Business Overview
10.6.3 Almac Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Almac Frovatriptan Products Offered
10.6.5 Almac Recent Development
10.7 Glenmark Generics
10.7.1 Glenmark Generics Company Information
10.7.2 Glenmark Generics Introduction and Business Overview
10.7.3 Glenmark Generics Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.7.4 Glenmark Generics Frovatriptan Products Offered
10.7.5 Glenmark Generics Recent Development
10.8 Teva
10.8.1 Teva Company Information
10.8.2 Teva Introduction and Business Overview
10.8.3 Teva Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Teva Frovatriptan Products Offered
10.8.5 Teva Recent Development
10.9 Zambon
10.9.1 Zambon Company Information
10.9.2 Zambon Introduction and Business Overview
10.9.3 Zambon Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Zambon Frovatriptan Products Offered
10.9.5 Zambon Recent Development
10.10 Apotex
10.10.1 Apotex Company Information
10.10.2 Apotex Introduction and Business Overview
10.10.3 Apotex Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Apotex Frovatriptan Products Offered
10.10.5 Apotex Recent Development
10.11 G.L. Pharma
10.11.1 G.L. Pharma Company Information
10.11.2 G.L. Pharma Introduction and Business Overview
10.11.3 G.L. Pharma Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.11.4 G.L. Pharma Frovatriptan Products Offered
10.11.5 G.L. Pharma Recent Development
10.12 Chanelle Pharma
10.12.1 Chanelle Pharma Company Information
10.12.2 Chanelle Pharma Introduction and Business Overview
10.12.3 Chanelle Pharma Frovatriptan Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Chanelle Pharma Frovatriptan Products Offered
10.12.5 Chanelle Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Frovatriptan Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Frovatriptan Industrial Chain Analysis
11.4 Frovatriptan Market Dynamics
11.4.1 Frovatriptan Industry Trends
11.4.2 Frovatriptan Market Drivers
11.4.3 Frovatriptan Market Challenges
11.4.4 Frovatriptan Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Frovatriptan Distributors
12.3 Frovatriptan Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Hospital
Table 2. Major Company of Drug Store
Table 3. Global Frovatriptan Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Frovatriptan Sales by Type (2024-2024) & (K Units)
Table 5. Global Frovatriptan Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Frovatriptan Sales by Type (2024-2024) & (US& Million)
Table 7. Global Frovatriptan Market Share in Value by Type (2024-2024)
Table 8. Global Frovatriptan Price by Type (2024-2024) & (US$/Unit)
Table 9. Global Frovatriptan Sales by Type (2024-2034) & (K Units)
Table 10. Global Frovatriptan Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Frovatriptan Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Frovatriptan Sales Market Share in Value by Type (2024-2034)
Table 13. Global Frovatriptan Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Frovatriptan Sales by Type (2024-2024) & (K Units)
Table 15. North America Frovatriptan Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Frovatriptan Sales (K Units) by Type (2024-2024)
Table 17. Europe Frovatriptan Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Frovatriptan Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific Frovatriptan Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Frovatriptan Sales (K Units) by Type (2024-2024)
Table 21. Latin America Frovatriptan Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Frovatriptan Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa Frovatriptan Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Frovatriptan Sales by Company (2024-2024) & (K Units)
Table 25. Global Frovatriptan Sales Share by Company (2024-2024)
Table 26. Global Frovatriptan Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Frovatriptan Revenue Share by Company (2024-2024)
Table 28. Global Market Frovatriptan Price by Company (2024-2024) & (US$/Unit)
Table 29. Global Frovatriptan Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Frovatriptan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Frovatriptan as of 2022)
Table 32. Date of Key Manufacturers Enter into Frovatriptan Market
Table 33. Key Manufacturers Frovatriptan Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Frovatriptan Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Frovatriptan Sales by Region (2024-2024) & (K Units)
Table 37. Global Frovatriptan Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Frovatriptan Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Frovatriptan Sales Market Share in Value by Region (2024-2024)
Table 40. Global Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global Frovatriptan Sales by Region (2024-2034) & (K Units)
Table 42. Global Frovatriptan Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Frovatriptan Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Frovatriptan Sales Market Share in Value by Region (2024-2034)
Table 45. Global Frovatriptan Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Frovatriptan Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Frovatriptan Sales by Application (2024-2024) & (K Units)
Table 48. Global Frovatriptan Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Frovatriptan Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Frovatriptan Sales Market Share in Value by Application (2024-2024)
Table 51. Global Frovatriptan Price by Application (2024-2024) & (US$/Unit)
Table 52. Global Frovatriptan Sales by Application (2024-2034) & (K Units)
Table 53. Global Frovatriptan Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Frovatriptan Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Frovatriptan Sales Market Share in Value by Application (2024-2034)
Table 56. Global Frovatriptan Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Frovatriptan Sales by Application (2024-2024) (K Units)
Table 58. North America Frovatriptan Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Frovatriptan Sales by Application (2024-2024) (K Units)
Table 60. Europe Frovatriptan Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Frovatriptan Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific Frovatriptan Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Frovatriptan Sales by Application (2024-2024) (K Units)
Table 64. Latin America Frovatriptan Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Frovatriptan Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa Frovatriptan Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Frovatriptan Sales by Country (2024-2024) & (K Units)
Table 68. North America Frovatriptan Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Frovatriptan Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Frovatriptan Sales Market Share in Value by Country (2024-2024)
Table 71. North America Frovatriptan Sales by Country (2024-2034) & (K Units)
Table 72. North America Frovatriptan Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Frovatriptan Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Frovatriptan Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Frovatriptan Sales by Country (2024-2024) & (K Units)
Table 76. Europe Frovatriptan Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Frovatriptan Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Frovatriptan Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Frovatriptan Sales by Country (2024-2034) & (K Units)
Table 80. Europe Frovatriptan Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Frovatriptan Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Frovatriptan Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Frovatriptan Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific Frovatriptan Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Frovatriptan Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Frovatriptan Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Frovatriptan Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Frovatriptan Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Frovatriptan Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Frovatriptan Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Frovatriptan Sales by Country (2024-2024) & (K Units)
Table 92. Latin America Frovatriptan Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Frovatriptan Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Frovatriptan Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Frovatriptan Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Frovatriptan Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Frovatriptan Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Frovatriptan Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Frovatriptan Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa Frovatriptan Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Frovatriptan Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Frovatriptan Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Frovatriptan Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Frovatriptan Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Frovatriptan Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Frovatriptan Sales Market Share in Value by Country (2024-2034)
Table 107. Ligand Pharmaceuticals Company Information
Table 108. Ligand Pharmaceuticals Introduction and Business Overview
Table 109. Ligand Pharmaceuticals Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Ligand Pharmaceuticals Frovatriptan Product
Table 111. Ligand Pharmaceuticals Recent Development
Table 112. Endo Pharmaceuticals Company Information
Table 113. Endo Pharmaceuticals Introduction and Business Overview
Table 114. Endo Pharmaceuticals Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Endo Pharmaceuticals Frovatriptan Product
Table 116. Endo Pharmaceuticals Recent Development
Table 117. Doc Generici Company Information
Table 118. Doc Generici Introduction and Business Overview
Table 119. Doc Generici Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Doc Generici Frovatriptan Product
Table 121. Doc Generici Recent Development
Table 122. Menarini Company Information
Table 123. Menarini Introduction and Business Overview
Table 124. Menarini Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Menarini Frovatriptan Product
Table 126. Menarini Recent Development
Table 127. Novartis Company Information
Table 128. Novartis Introduction and Business Overview
Table 129. Novartis Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Novartis Frovatriptan Product
Table 131. Novartis Recent Development
Table 132. Almac Company Information
Table 133. Almac Introduction and Business Overview
Table 134. Almac Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Almac Frovatriptan Product
Table 136. Almac Recent Development
Table 137. Glenmark Generics Company Information
Table 138. Glenmark Generics Introduction and Business Overview
Table 139. Glenmark Generics Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. Glenmark Generics Frovatriptan Product
Table 141. Glenmark Generics Recent Development
Table 142. Teva Company Information
Table 143. Teva Introduction and Business Overview
Table 144. Teva Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 145. Teva Frovatriptan Product
Table 146. Teva Recent Development
Table 147. Zambon Company Information
Table 148. Zambon Introduction and Business Overview
Table 149. Zambon Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 150. Zambon Frovatriptan Product
Table 151. Zambon Recent Development
Table 152. Apotex Company Information
Table 153. Apotex Introduction and Business Overview
Table 154. Apotex Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 155. Apotex Frovatriptan Product
Table 156. Apotex Recent Development
Table 157. G.L. Pharma Company Information
Table 158. G.L. Pharma Introduction and Business Overview
Table 159. G.L. Pharma Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 160. G.L. Pharma Frovatriptan Product
Table 161. G.L. Pharma Recent Development
Table 162. Chanelle Pharma Company Information
Table 163. Chanelle Pharma Introduction and Business Overview
Table 164. Chanelle Pharma Frovatriptan Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 165. Chanelle Pharma Frovatriptan Product
Table 166. Chanelle Pharma Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Frovatriptan Market Trends
Table 170. Frovatriptan Market Drivers
Table 171. Frovatriptan Market Challenges
Table 172. Frovatriptan Market Restraints
Table 173. Frovatriptan Distributors List
Table 174. Frovatriptan Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Frovatriptan Product Picture
Figure 2. Global Frovatriptan Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Frovatriptan Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Frovatriptan Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Hospital
Figure 6. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Drug Store
Figure 8. Global Drug Store Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global Frovatriptan Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Frovatriptan Sales Market Share by Type in 2022 & 2034
Figure 11. North America Frovatriptan Sales Market Share in Volume by Type in 2022
Figure 12. North America Frovatriptan Sales Market Share in Value by Type in 2022
Figure 13. Europe Frovatriptan Sales Market Share in Volume by Type in 2022
Figure 14. Europe Frovatriptan Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Frovatriptan Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Frovatriptan Sales Market Share in Value by Type in 2022
Figure 17. Latin America Frovatriptan Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Frovatriptan Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Frovatriptan Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Frovatriptan Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Frovatriptan Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Frovatriptan Revenue in 2022
Figure 23. Frovatriptan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Menstrual Migraines
Figure 25. Global Menstrual Migraines Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Migraine with Aura
Figure 27. Global Migraine with Aura Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Migraine without Aura
Figure 29. Global Migraine without Aura Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global Frovatriptan Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Frovatriptan Sales Market Share by Application in 2022 & 2034
Figure 32. North America Frovatriptan Sales Market Share in Volume by Application in 2022
Figure 33. North America Frovatriptan Sales Market Share in Value by Application in 2022
Figure 34. Europe Frovatriptan Sales Market Share in Volume by Application in 2022
Figure 35. Europe Frovatriptan Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Frovatriptan Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Frovatriptan Sales Market Share in Value by Application in 2022
Figure 38. Latin America Frovatriptan Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Frovatriptan Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Frovatriptan Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Frovatriptan Manufacturing Cost Structure
Figure 43. Frovatriptan Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed